Saxenda (liraglutide) is a GLP-1 agonist injection pen medication. It helps with sustained weight loss for adults with obesity, adults with overweight who are experiencing weight-related health issues ...

Saxenda (liraglutide) is a GLP-1 agonist injection pen medication used to support long-term weight loss in adults with obesity, adults with overweight and weight-related health issues, and certain ...

After Novo Nordisk’s popular obesity medicine Wegovy went into short supply, people turned to the company’s first-generation weight-loss drug, Saxenda, for treatment. Now, the company is struggling to ...

Saxenda (liraglutide) and Wegovy (semaglutide) are brand-name injections. They’re both prescribed for weight loss and long-term weight management. Saxenda is used daily, while Wegovy is used weekly.

More than half of people prescribed weight-loss drugs Saxenda and Wegovy over the past decade ended their treatment too early to realize meaningful health benefits, according to a study by a major U.S ...

Teva's generic Saxenda is the first generic GLP-1 indicated for weight loss. Richardsen added, “This is the fifth first-to-market entry of a Teva generic this year and is an important addition to Teva ...

Novo Nordisk bet big on its GLP-1 med Saxenda in obesity, despite rivals' failures to expand the global market. But payers in England have put up a roadblock that could hurt the Danish drugmaker's ...

World Health Organization advisors will meet next month to decide whether liraglutide will be added to the organization’s updated Essential Medicines List, making the drug available in all hospital ...